Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in Central China

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Sun, Min ^a   Gao, Lei ^a   Liu, Ying ^a   Zhao, Yiqiang ^a   Wang, Xueqian ^a   Pan, Yaqi ^a   Ning, Tao ^a   Cai, Hong ^a   Yang, Haijun ^c   Zhai, Weiwei ^b   Ke, Yang ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b China National Center for Bioinformation   (China)

^c Anyang Cancer Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ARTICLE; CONTROLLED STUDY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNOGENICITY; IMMUNOSURVEILLANCE; MOLECULAR EVOLUTION; NONHUMAN; PHENOTYPE; PHYLOGENETIC TREE; PHYLOGENY; POLYMERASE CHAIN REACTION; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS ISOLATION; CHINA; CODON; DNA SEQUENCE; FEMALE; GENETIC SELECTION; GENETICS; HUMAN; PATHOGENICITY; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS GENE;

HUMAN PAPILLOMAVIRUS TYPE 16;

VIRUS DNA;

CHINA; CODON; DNA, VIRAL; EVOLUTION, MOLECULAR; FEMALE; GENES, VIRAL; GENETIC VARIATION; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; PHYLOGENY; POLYMERASE CHAIN REACTION; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; UTERINE CERVICAL NEOPLASMS;

EID: 84860521692     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036577     Document Type: Article

References (78)

1. Parkin DM, (2006) The global health burden of infection-associated cancers in the year 2002. Int J Cancer 118: 3030-3044.
2. Clifford GM, Smith JS, Aguado T, Franceschi S, (2003) Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 89: 101-105.
3. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S, (2003) Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88: 63-73.
4. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527.
5. Cogliano V, Baan R, Straif K, Grosse Y, Secretan B, et al. (2005) Carcinogenicity of human papillomaviruses. Lancet Oncol 6: 204.
6. IARC, (2007) Human papillomaviruses (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, IARC Monographs, Volume 90). Lyon, France IARC.
7. Munoz N, Bosch FX, Castellsague X, Diaz M, de Sanjose S, et al. (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111: 278-285.
8. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S, (2007) Human papillomavirus and cervical cancer. Lancet 370: 890-907.
9. Bernard HU, Calleja-Macias IE, Dunn ST, (2006) Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 118: 1071-1076.
10. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, (2004) Classification of papillomaviruses. Virology 324: 17-27.
11. Picconi MA, Alonio LV, Sichero L, Mbayed V, Villa LL, et al. (2003) Human papillomavirus type-16 variants in Quechua aboriginals from Argentina. J Med Virol 69: 546-552.
12. Yamada T, Manos MM, Peto J, Greer CE, Munoz N, et al. (1997) Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71: 2463-2472.
13. Bernard HU, (2008) Genome Diversity and Evolution of Papillomaviruses. In: Esteban Domingo, Colin R Parrish, Holland JJ, editors. Origin and Evolution of Viruses 2nd ed Academic Press.
14. Chen Z, Terai M, Fu L, Herrero R, DeSalle R, et al. (2005) Diversifying selection in human papillomavirus type 16 lineages based on complete genome analyses. J Virol 79: 7014-7023.
15. Cai HB, Chen CC, Ding XH, (2010) Human papillomavirus type 16 E6 gene variations in Chinese population. Eur J Surg Oncol 36: 160-163.
16. Chan PK, Lam CW, Cheung TH, Li WW, Lo KW, et al. (2002) Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 186: 696-700.
17. Choo KB, Wang TS, Huang CJ, (2000) Analysis of relative binding affinity of E7-pRB of human papillomavirus 16 clinical variants using the yeast two-hybrid system. J Med Virol 61: 298-302.
18. Ding T, Wang X, Ye F, Cheng X, Lu W, et al. (2011) Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women. Int J Gynecol Cancer 20: 1391-1398.
19. Hu Y, Zhu YY, Zhang SH, Zhu H, Shuai CX, (2011) Human papillomavirus type 16 e6 gene variations in young chinese women with cervical squamous cell carcinoma. Reprod Sci 18: 406-412.
20. Qiu AD, Wu EQ, Yu XH, Jiang CL, Jin YH, et al. (2007) HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China. Gynecol Oncol 104: 77-85.
21. Shang Q, Wang Y, Fang Y, Wei L, Chen S, et al. (2011) Human papillomavirus type 16 variant analysis of e6, e7, and l1 genes and long control region in identification of cervical carcinomas in patients in northeast china. J Clin Microbiol 49: 2656-2663.
22. Sun Z, Ren G, Cui X, Zhou W, Liu C, et al. (2011) Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer 21: 551-558.
23. Wu Y, Chen Y, Li L, Yu G, He Y, et al. (2006) Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China. J Gen Virol 87: 1181-1188.
24. Xiong GW, Yuan Y, Li M, Guo HY, Zhang XW, (2010) [Human papillomavirus type 16 variant analysis of upstream regulatory region and E6, E7 oncogene from cervical cancer patients in Beijing]. Yi Chuan 32: 339-347.
25. MacCallum C, Hill E, (2006) Being Positive about Selection. PLoS Biology 4: e87.
26. Kimura M, (1977) Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 267: 275-276.
27. Miyata T, Miyazawa S, Yasunaga T, (1979) Two types of amino acid substitutions in protein evolution. J Mol Evol 12: 219-236.
28. Nei M, Gojobori T, (1986) Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3: 418-426.
29. Suzuki Y, Gojobori T, (1999) A method for detecting positive selection at single amino acid sites. Mol Biol Evol 16: 1315-1328.
30. Goldman N, Yang Z, (1994) A codon-based model of nucleotide substitution for protein-coding DNA sequences. Mol Biol Evol 11: 725-736.
31. Muse SV, Gaut BS, (1994) A likelihood approach for comparing synonymous and nonsynonymous nucleotide substitution rates, with application to the chloroplast genome. Mol Biol Evol 11: 715-724.
32. Nielsen R, Yang Z, (1998) Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. Genetics 148: 929-936.
33. Yang Z, Nielsen R, Goldman N, Pedersen AM, (2000) Codon-substitution models for heterogeneous selection pressure at amino acid sites. Genetics 155: 431-449.
34. Yang Z, Wong WS, Nielsen R, (2005) Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 22: 1107-1118.
35. Kosiol C, Vinar T, da Fonseca RR, Hubisz MJ, Bustamante CD, et al. (2008) Patterns of positive selection in six Mammalian genomes. PLoS Genet 4: e1000144.
36. Wang X, Tian X, Liu F, Zhao Y, Sun M, et al. (2010) Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 10: 19.
37. Edgar RC, (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32: 1792-1797.
38. Meyers G, Baker C, Münger K, Svedrup F, McBride A, et al.eds. (1997) Human papillomaviruses 1997. A compilation and analysis of nucleic acid and amino acid sequences. Los Alamos, NM Los Alamos National Laboratory.
39. Seedorf K, Krammer G, Durst M, Suhai S, Rowekamp WG, (1985) Human papillomavirus type 16 DNA sequence. Virology 145: 181-185.
40. Guindon S, Gascuel O, (2003) A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52: 696-704.
41. Sukumaran J, Holder MT, (2010) DendroPy: a Python library for phylogenetic computing. Bioinformatics 26: 1569-1571.
42. Tajima F, (1989) Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 123: 585-595.
43. Watterson GA, (1975) On the number of segregating sites in genetical models without recombination. Theor Popul Biol 7: 256-276.
44. Yang Z, (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24: 1586-1591.
45. Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, et al. (2004) Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade. Gynecol Oncol 92: 873-880.
46. Peitsaro P, Johansson B, Syrjanen S, (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40: 886-891.
47. Sharp PM, (2002) Origins of human virus diversity. Cell 108: 305-312.
48. Slatkin M, Hudson RR, (1991) Pairwise comparisons of mitochondrial DNA sequences in stable and exponentially growing populations. Genetics 129: 555-562.
49. Andersson S, Alemi M, Rylander E, Strand A, Larsson B, et al. (2000) Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions. Br J Cancer 83: 307-310.
50. Zehbe I, Mytilineos J, Wikstrom I, Henriksen R, Edler L, et al. (2003) Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women. Hum Immunol 64: 538-542.
51. de Araujo Souza PS, Maciag PC, Ribeiro KB, Petzl-Erler ML, Franco EL, et al. (2008) Interaction between polymorphisms of the human leukocyte antigen and HPV-16 variants on the risk of invasive cervical cancer. BMC Cancer 8: 246.
52. Zehbe I, Tachezy R, Mytilineos J, Voglino G, Mikyskova I, et al. (2001) Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int J Cancer 94: 711-716.
53. Chakrabarti O, Veeraraghavalu K, Tergaonkar V, Liu Y, Androphy EJ, et al. (2004) Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated MAPK signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J Virol 78: 5934-5945.
54. Asadurian Y, Kurilin H, Lichtig H, Jackman A, Gonen P, et al. (2007) Activities of human papillomavirus 16 E6 natural variants in human keratinocytes. J Med Virol 79: 1751-1760.
55. Lichtig H, Algrisi M, Botzer LE, Abadi T, Verbitzky Y, et al. (2006) HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6. Virology 350: 216-227.
56. van Duin M, Snijders PJ, Vossen MT, Klaassen E, Voorhorst F, et al. (2000) Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 81: 317-325.
57. Matsumoto K, Yasugi T, Nakagawa S, Okubo M, Hirata R, et al. (2003) Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer. Int J Cancer 106: 919-922.
58. Matsumoto K, Yoshikawa H, Nakagawa S, Tang X, Yasugi T, et al. (2000) Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156: 159-165.
59. Bravo IG, Alonso A, (2004) Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth. J Virol 78: 13613-13626.
60. Chen Z, Schiffman M, Herrero R, Desalle R, Anastos K, et al. (2011) Evolution and taxonomic classification of human papillomavirus 16 (HPV16)-related variant genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLoS One 6: e20183.
61. Garcia-Vallve S, Alonso A, Bravo IG, (2005) Papillomaviruses: different genes have different histories. Trends Microbiol 13: 514-521.
62. Smith B, Chen Z, Reimers L, van Doorslaer K, Schiffman M, et al. (2011) Sequence imputation of HPV16 genomes for genetic association studies. PLoS One 6: e21375.
63. Jones RE, Wegrzyn RJ, Patrick DR, Balishin NL, Vuocolo GA, et al. (1990) Identification of HPV-16 E7 peptides that are potent antagonists of E7 binding to the retinoblastoma suppressor protein. J Biol Chem 265: 12782-12785.
64. Stephen AL, Thompson CH, Tattersall MH, Cossart YE, Rose BR, (2000) Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 86: 695-701.
65. Masterson PJ, Stanley MA, Lewis AP, Romanos MA, (1998) A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J Virol 72: 7407-7419.
66. Blakaj DM, Fernandez-Fuentes N, Chen Z, Hegde R, Fiser A, et al. (2009) Evolutionary and biophysical relationships among the papillomavirus E2 proteins. Front Biosci 14: 900-917.
67. Giannoudis A, Duin M, Snijders PJ, Herrington CS, (2001) Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 84: 1058-1063.
68. Smith JM, Haigh J, (1974) The hitch-hiking effect of a favourable gene. Genet Res 23: 23-35.
69. Hildesheim A, Schiffman M, Bromley C, Wacholder S, Herrero R, et al. (2001) Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 93: 315-318.
70. Villa LL, Sichero L, Rahal P, Caballero O, Ferenczy A, et al. (2000) Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 81: 2959-2968.
71. Xi LF, Carter JJ, Galloway DA, Kuypers J, Hughes JP, et al. (2002) Acquisition and natural history of human papillomavirus type 16 variant infection among a cohort of female university students. Cancer Epidemiol Biomarkers Prev 11: 343-351.
72. Giannoudis A, Herrington CS, (2001) Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 193: 295-302.
73. Chin CS, Sorenson J, Harris JB, Robins WP, Charles RC, et al. (2011) The origin of the Haitian cholera outbreak strain. N Engl J Med 364: 33-42.
74. Zheng ZM, Baker CC, (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302.
75. Kang S, Jeon YT, Kim JW, Park NH, Song YS, et al. (2005) Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 15: 107-112.
76. Pande S, Jain N, Prusty BK, Bhambhani S, Gupta S, et al. (2008) Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J Clin Microbiol 46: 1060-1066.
77. Vaeteewoottacharn K, Jearanaikoon P, Ponglikitmongkol M, (2003) Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. Anticancer Res 23: 1927-1931.
78. de Boer MA, Peters LA, Aziz MF, Siregar B, Cornain S, et al. (2004) Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94: 488-494.